WatsonIDTamesFJBorlandWSmithB.Unequivocal epidemiology of substance abuse in cities in the UK. Ther Drug Monit1993; 15: 175.
2.
SimpsonDGreenwoodJJarvieDRMooreFML.Experience of a laboratory service for drug screening in urine. Scot Med J1993; 38: 20–6.
3.
GeorgeSBraithwaiteRA.Drugs of abuse screening in the West Midlands: a 6 year retrospective survey of results. Ann Clin Biochem1994; 31: 473–8.
4.
BraithwaiteRAJarvieDRMintyPSBSimpsonDWiddopB.Screening for drugs of abuse. I: Opiates, amphetamines and cocaine. Ann Clin Biochem1995; 32: 123–53.
5.
KunsmanGWMannoJECockerhamKRMannoBR.Application of Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyethamphetamine (MDEA) in urine. J Anal Toxicol1990; 14: 149–53.
6.
PoklisAHallKVEddletonRAFitzgeraldRLSaadyJJBogemaSC.EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. I Stereoselectivity and clinical evaluation. Forensic Sci Int.1993; 59: 49–62.
7.
PoklisAFitzgeraldRLHallKVSaadyJJ.Emit-d.a.u. monoclonal amphetamine/methamphetamine assay. II Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA). Forensic Sci Int.1993; 59: 63–70.
8.
OlsenKMGulliksenMChristophersenAS.Metabolites of chlorpromazine and brompheniramine may cause false-posiitve urine amphetamine results with monoclonal EMIT d.a.u. immunoassay [Letter]. Clin Chem1992; 38: 611–12.
9.
CraneTDawsonCMTicknerTR.False-positive results from the Syva EMIT d.a.u. monoclonal amphetamine assay as a result of antipsychotic drug therapy [Letter]. Clin Chem1993; 39: 549.
10.
MooreFMLJarvieDRSimpsonD.Urinary amphetamines, benzodiazepines and methadone; cost effective detection procedures. Med Lab Sci.1992; 49: 27–33.
11.
DasguptaASaldaneSKinnamanGSmithMJohansenK.Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay. Clin Chem1993; 39: 104–8.